info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Bioresorbable Scaffolds Market Research Report, by Material (absorbable magnesium stent (AMS), polymeric scaffold, poly carbonate scaffold and others), by Types (drug eluting coronary scaffolds, everolimus-eluting device, novolimus-eluting device, sirolimus-eluting device, paclitaxel-eluting device), by Applications (peripheral vascular intervention, regulation of blood flow and others) by End Users (hospitals, clinics and others) - Forecast till 2030


ID: MRFR/MED/0743-HCR | 130 Pages | Author: Kinjoll Dey| June 2024

Bioresorbable Scaffolds Market Overview


The Bioresorbable Scaffolds Market is projected to reach USD 2,920.6 Million by 2030 at 19.9% CAGR during the forecast period 2022-2030. Bioresorbable scaffolds are medical devices used during numerous surgeries, as required when one suffers from coronary artery disease; bioresorbable scaffolds are recently introduced medical devices. Major driving factors for the growth of this market are increasing prevalence of cardiovascular disease, diabetes, obesity, poor diet and lack of exercise. According to WHO (2014), cardiovascular diseases accounted for a majority of deaths globally.


Bioresorbable Scaffolds Market


Moreover, number of obese population across the globe is rising continuously. In 2014, globally 39% of adults aged 18 years and above were overweight, whereas 13% were obese. Furthermore, rapid development in devices used for cardiovascular surgeries, rising demand for bioresorbable scaffolds, adoption of desk-bound lifestyle, and government’s support for research and development of better medical devices has fuelled the bioresorbable scaffolds market growth. However, availability of alternative therapies and high cost of the bioresorbable scaffolds may slower the growth of this market.


Bioresorbable Scaffolds Market Segment Insights


The bioresorbable scaffolds market is segmented on the basis of material, types, application and end users. On the basis of material, the market is classified into absorbable magnesium stent (AMS), polymeric scaffold, poly carbonate scaffold and others. On the basis of types, the market is segmented into drug eluting coronary scaffolds, everolimus-eluting device, novolimus-eluting device, sirolimus-eluting device, and paclitaxel-eluting device. On the basis of application, the market is segmented into peripheral vascular intervention, regulation of blood flow and others. On the basis of end users, the market is categorised into hospitals, clinics and others.


Bioresorbable Scaffolds Market Regional Analysis


The global bioresorbable scaffolds market is dominated by America, owing to the presence of huge population suffering from cardiovascular diseases, presence of number of leading companies and increasing geriatric population. Moreover, increasing obese and diabetic population, lack of exercise, increasing stress and desk-bound lifestyle have provided a push for the growth of the market. Europe has the second largest market, which is followed by Asia Pacific. Asia Pacific accounts for the fastest growing market, due to rapid development in technology and a huge number of patients suffering from different vascular diseases. The Middle East & Africa accounts the least share in global bioresorbable scaffolds market.


Bioresorbable Scaffolds Market Key Players



  • Abbott (US)

  • Medtronic (UK)

  • Boston Scientific Corporation (US)

  • Biotronik (Germany)

  • Elixir Medical Corporation (US)

  • REVA Medical, Inc (US)

  • Amaranth Medical, Inc. (US)

  • Kyoto Medical Planning Co. Ltd. (Japan)

  • Xenogenics Corporation (US)

  • B. Braun (Germany)

  • Cardinal Health. (US)

  • Lombard Medical, Inc (UK)

  • Translumina (Germany)

  • MicroPort Scientific Corporation (China)

  • TERUMO CORPORATION (Japan).


Bioresorbable Scaffolds Market Intended Audience



  • Medical devices manufacturing companies

  • Research and development (R&D) companies

  • Government and independent research laboratories

  • Government and independent regulatory authorities

  • Academic medical institutes and universities

  • Pharmaceutical industries

Report Attribute/Metric Details
  Market Size   2030: USD 2,920.6 Million
  CAGR   19.9%
  Base Year   2021
Forecast Period   2022-2030
Historical Data   2020
Forecast Units   Value (USD Million)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors and Trends
Segments Covered Material, types, application and end users
Geographies Covered North America, Europe, Asia-Pacific and Rest of the World (RoW)
  Key Vendors Abbott (US), Medtronic (UK), Boston Scientific Corporation (US), Biotronik (Germany), Elixir Medical Corporation (US), REVA Medical, Inc (US), Amaranth Medical, Inc. (US), Kyoto Medical Planning Co. Ltd. (Japan), Xenogenics Corporation (US), B. Braun (Germany), Cardinal Health. (US), Lombard Medical, Inc (UK), Translumina (Germany), MicroPort Scientific Corporation (China) and TERUMO CORPORATION (Japan)
Key Market Opportunities Research and development
Key Market Drivers Increasing prevalence of cardiovascular disease, diabetes, obesity, poor diet


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.